Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1193798

Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents


Poje, Goran; Pessanha de Carvalho, Lais; Held, Jana; Moita, Diana; Prudêncio, Miguel; Perković, Ivana; Tandarić, Tana; Vianello, Robert; Rajić, Zrinka
Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents // European journal of medicinal chemistry, 238 (2022), 114408, 15 doi:10.1016/j.ejmech.2022.114408 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1193798 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents

Autori
Poje, Goran ; Pessanha de Carvalho, Lais ; Held, Jana ; Moita, Diana ; Prudêncio, Miguel ; Perković, Ivana ; Tandarić, Tana ; Vianello, Robert ; Rajić, Zrinka

Izvornik
European journal of medicinal chemistry (0223-5234) 238 (2022); 114408, 15

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Harmine ; β-Carboline ; Chloroquine ; Hybrid compounds ; Antiplasmodial activity ; PfHsp90 ; P. falciparum

Sažetak
Malaria remains one of the major health problems worldwide. The lack of an effective vaccine and the increasing resistance of Plasmodium to the approved antimalarial drugs demands the development of novel antiplasmodial agents that can effectively prevent and/or treat this disease. Harmiquins represent hybrids that combine two moieties with different mechanisms of antiplasmodial activity in one molecule, i.e., a chloroquine (CQ) scaffold, known to inhibit heme polymerization and a β-carboline ring capable of binding to P. falciparum heat shock protein 90 (PfHsp90). Here we present their synthesis, evaluation of biological activity and potential mechanism of action. The synthesized hybrids differed in the type of linker employed (triazole ring or amide bond) and in the position of the substitution on the β-carboline core of harmine. The antiplasmodial activity of harmiquins was evaluated against the erythrocytic stage of the Plasmodium life cycle, and their cytotoxic effect was tested on HepG2 cells. The results showed that harmiquins exerted remarkable activity against both CQ-sensitive (Pf3D7) and CQ-resistant (PfDd2, PfK1, and Pf7G8). P. falciparum strains. The most active compound, harmiquine 32, displayed single-digit nanomolar IC50 value against Pf3D7 (IC50 = 2.0 ± 0.3 nM). Importantly, it also showed significantly higher activity than CQ against the resistant Plasmodium strains and had a very high selectivity index (4450). Harmiquins may act through the inhibition of heme polymerization and binding to the ATP binding site of the PfHsp90, which would explain their increased activity against the CQ-resistant Plasmodium strains. These results establish harmiquins as valuable antiplasmodial hits for future optimization.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Farmacija



POVEZANOST RADA


Projekti:
UIP-2017-05-5160 - Derivati harmina kao potencijalni antimalarici (CLICKforMALARIA) (Rajić Džolić, Zrinka, HRZZ - 2017-05) ( CroRIS)

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Zrinka Rajić (autor)

Avatar Url Goran Poje (autor)

Avatar Url Tana Tandarić (autor)

Avatar Url Ivana Perković (autor)

Avatar Url Robert Vianello (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com doi.org

Citiraj ovu publikaciju:

Poje, Goran; Pessanha de Carvalho, Lais; Held, Jana; Moita, Diana; Prudêncio, Miguel; Perković, Ivana; Tandarić, Tana; Vianello, Robert; Rajić, Zrinka
Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents // European journal of medicinal chemistry, 238 (2022), 114408, 15 doi:10.1016/j.ejmech.2022.114408 (međunarodna recenzija, članak, znanstveni)
Poje, G., Pessanha de Carvalho, L., Held, J., Moita, D., Prudêncio, M., Perković, I., Tandarić, T., Vianello, R. & Rajić, Z. (2022) Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents. European journal of medicinal chemistry, 238, 114408, 15 doi:10.1016/j.ejmech.2022.114408.
@article{article, author = {Poje, Goran and Pessanha de Carvalho, Lais and Held, Jana and Moita, Diana and Prud\^{e}ncio, Miguel and Perkovi\'{c}, Ivana and Tandari\'{c}, Tana and Vianello, Robert and Raji\'{c}, Zrinka}, year = {2022}, pages = {15}, DOI = {10.1016/j.ejmech.2022.114408}, chapter = {114408}, keywords = {Harmine, β-Carboline, Chloroquine, Hybrid compounds, Antiplasmodial activity, PfHsp90, P. falciparum}, journal = {European journal of medicinal chemistry}, doi = {10.1016/j.ejmech.2022.114408}, volume = {238}, issn = {0223-5234}, title = {Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents}, keyword = {Harmine, β-Carboline, Chloroquine, Hybrid compounds, Antiplasmodial activity, PfHsp90, P. falciparum}, chapternumber = {114408} }
@article{article, author = {Poje, Goran and Pessanha de Carvalho, Lais and Held, Jana and Moita, Diana and Prud\^{e}ncio, Miguel and Perkovi\'{c}, Ivana and Tandari\'{c}, Tana and Vianello, Robert and Raji\'{c}, Zrinka}, year = {2022}, pages = {15}, DOI = {10.1016/j.ejmech.2022.114408}, chapter = {114408}, keywords = {Harmine, β-Carboline, Chloroquine, Hybrid compounds, Antiplasmodial activity, PfHsp90, P. falciparum}, journal = {European journal of medicinal chemistry}, doi = {10.1016/j.ejmech.2022.114408}, volume = {238}, issn = {0223-5234}, title = {Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents}, keyword = {Harmine, β-Carboline, Chloroquine, Hybrid compounds, Antiplasmodial activity, PfHsp90, P. falciparum}, chapternumber = {114408} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font